HK1217490A1 - 黃斑變性治療中的新穎捕獲劑 - Google Patents
黃斑變性治療中的新穎捕獲劑 Download PDFInfo
- Publication number
- HK1217490A1 HK1217490A1 HK16105524.6A HK16105524A HK1217490A1 HK 1217490 A1 HK1217490 A1 HK 1217490A1 HK 16105524 A HK16105524 A HK 16105524A HK 1217490 A1 HK1217490 A1 HK 1217490A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- macular degeneration
- treatment
- traps
- novel
- novel traps
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756778P | 2013-01-25 | 2013-01-25 | |
| US61/756,778 | 2013-01-25 | ||
| PCT/US2014/012356 WO2014116593A1 (en) | 2013-01-25 | 2014-01-21 | Novel traps in the treatment of macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1217490A1 true HK1217490A1 (zh) | 2017-01-13 |
Family
ID=51227964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16105524.6A HK1217490A1 (zh) | 2013-01-25 | 2014-01-21 | 黃斑變性治療中的新穎捕獲劑 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10111862B2 (enExample) |
| EP (1) | EP2948436A4 (enExample) |
| JP (1) | JP6266023B2 (enExample) |
| KR (1) | KR20150120380A (enExample) |
| CN (1) | CN105228989A (enExample) |
| AU (1) | AU2014209585A1 (enExample) |
| CA (1) | CA2898869A1 (enExample) |
| HK (1) | HK1217490A1 (enExample) |
| IL (1) | IL239736A0 (enExample) |
| MX (1) | MX2015009444A (enExample) |
| RU (1) | RU2015126015A (enExample) |
| SG (1) | SG11201505599YA (enExample) |
| WO (1) | WO2014116593A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006249866B2 (en) | 2005-05-26 | 2011-10-13 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
| CA2782015C (en) | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
| KR20150118106A (ko) | 2012-12-20 | 2015-10-21 | 알데이라 테라퓨틱스, 아이엔씨. | 페리-카르비놀 |
| CN111135171B (zh) | 2013-01-23 | 2023-09-08 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US20170298081A1 (en) * | 2014-08-08 | 2017-10-19 | Kasuma Partners Inc. | Condensed heterocyclic compound |
| CN118724806A (zh) * | 2015-08-21 | 2024-10-01 | 奥尔德拉医疗公司 | 氘化化合物和其用途 |
| KR20180116416A (ko) | 2016-02-28 | 2018-10-24 | 알데이라 테라퓨틱스, 아이엔씨. | 사이클로덱스트린으로의 알레르기성 안질환의 치료 |
| CN109152774A (zh) | 2016-05-09 | 2019-01-04 | 奥尔德拉医疗公司 | 眼部炎性病症和疾病的组合治疗 |
| WO2018170476A1 (en) * | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| CN111356451A (zh) | 2017-10-10 | 2020-06-30 | 奥尔德拉医疗公司 | 炎性病症的治疗 |
| CN112714762A (zh) | 2018-08-06 | 2021-04-27 | 奥尔德拉医疗公司 | 多晶型化合物及其用途 |
| CN113056353B (zh) | 2018-09-25 | 2022-11-01 | 奥尔德拉医疗公司 | 用于治疗干眼病的调配物 |
| US11786518B2 (en) | 2019-03-26 | 2023-10-17 | Aldeyra Therapeutics, Inc. | Ophthalmic formulations and uses thereof |
| US12098132B2 (en) | 2019-05-02 | 2024-09-24 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| CN113784954A (zh) | 2019-05-02 | 2021-12-10 | 奥尔德拉医疗公司 | 多晶型化合物和其用途 |
| US20220313722A1 (en) * | 2019-09-09 | 2022-10-06 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb |
| JP2023507900A (ja) * | 2019-12-30 | 2023-02-28 | 中国医▲薬▼研究▲開▼▲発▼中心有限公司 | 三環式化合物、及びその調製方法、及びその医薬的使用 |
| WO2021231792A1 (en) | 2020-05-13 | 2021-11-18 | Aldeyra Therapeutics, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2086186A (en) | 1933-10-10 | 1937-07-06 | Us Rubber Co | Treatment of rubber |
| GB1435721A (en) | 1972-05-18 | 1976-05-12 | Lilly Industries Ltd | Benzoxazole derivatives |
| SU509046A1 (ru) | 1975-02-21 | 1984-06-23 | Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе | Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени |
| US4675332A (en) | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
| GB8610981D0 (en) | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| AU641052B2 (en) | 1990-11-02 | 1993-09-09 | Aventisub Ii Inc. | 3-amidoindolyl derivatives |
| US5668117A (en) | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| US20050090553A1 (en) | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| US6444221B1 (en) | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
| US5472954A (en) | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| US5493027A (en) | 1993-01-22 | 1996-02-20 | Board Of Regents, The University Of Texas System | Anticonvulsive agents and uses thereof |
| US5597823A (en) | 1995-01-27 | 1997-01-28 | Abbott Laboratories | Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
| US5742954A (en) | 1996-11-22 | 1998-04-28 | Softub, Inc. | Electrically powered spa jet unit |
| AU8330898A (en) | 1997-05-02 | 1998-11-27 | Schering Aktiengesellschaft | Substituted heterocycles and their use in medicaments |
| JP2004500308A (ja) | 1998-03-12 | 2004-01-08 | ノボ ノルディスク アクティーゼルスカブ | プロテインチロシンホスアターゼのモジュレーター |
| US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
| WO2001041757A1 (en) | 1999-12-10 | 2001-06-14 | Senju Pharmaceutical Co., Ltd. | Cyclodextrin-containing pharmaceutical composition |
| US6569879B2 (en) * | 2000-02-18 | 2003-05-27 | Merck & Co., Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
| FR2827599A1 (fr) | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
| UA83620C2 (ru) | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
| CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| US20060281821A1 (en) | 2003-03-14 | 2006-12-14 | Krzysztof Palczewski | Retinoid replacements and opsin agonists and methods for the use thereof |
| EP1621199B8 (en) | 2003-04-18 | 2011-01-19 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
| US20060111318A1 (en) | 2003-04-18 | 2006-05-25 | Advanced Medicine Research Institute | Agent for treating eye diseases |
| US20040235892A1 (en) | 2003-05-22 | 2004-11-25 | Yujia Dai | Indazole and benzisoxazole kinase inhibitors |
| US7297709B2 (en) * | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| TWI344961B (en) | 2003-10-15 | 2011-07-11 | Ube Industries | Novel indazole derivative |
| CN100558360C (zh) | 2003-11-20 | 2009-11-11 | 奥特拉控股公司 | 羟胺组合物在制备缓解黄斑变性和其他眼科疾病的药物中的用途 |
| US20050197292A1 (en) | 2004-01-30 | 2005-09-08 | Glennda Smithson | Compositions and methods for treating T-cell mediated pathological conditions |
| WO2005079774A2 (en) | 2004-02-17 | 2005-09-01 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
| US20050234018A1 (en) | 2004-04-15 | 2005-10-20 | Allergan, Inc. | Drug delivery to the back of the eye |
| WO2006002473A1 (en) | 2004-07-02 | 2006-01-12 | Adelaide Research & Innovation Pty Ltd | Method of controlling damage mediated by alpha, beta-unsaturated aldehydes |
| US20070287716A1 (en) | 2004-10-28 | 2007-12-13 | Hu Essa H | Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors |
| TW200640443A (en) | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
| AU2006249866B2 (en) | 2005-05-26 | 2011-10-13 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
| BRPI0722382A2 (pt) | 2006-04-14 | 2012-06-05 | Prana Biotechnology Ltd | compostos úteis para o tratamento de cáncer |
| EP2079699A1 (en) | 2006-07-25 | 2009-07-22 | Envivo Pharmaceuticals, Inc. | Quinoline derivatives |
| MX2010003667A (es) | 2007-10-05 | 2010-09-28 | Acucela Inc | Compuestos alcoxi para el tratamiento de enfermedades. |
| WO2010019606A1 (en) | 2008-08-12 | 2010-02-18 | Sirtris Pharmaceuticals, Inc. | Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| WO2010133672A1 (en) | 2009-05-20 | 2010-11-25 | Clanotech Ab | Derivatives of quinoline-3-carboxylic acid and their medical use |
| EP2477594A4 (en) | 2009-07-15 | 2013-03-13 | Univ Vanderbilt | ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY |
| WO2011071995A2 (en) | 2009-12-08 | 2011-06-16 | Case Western Reserve University | Compounds and methods of treating ocular disorders |
| CA2782015C (en) * | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
| MX346387B (es) | 2011-01-12 | 2017-03-02 | Ventirx Pharmaceuticals Inc | Benzoazepinas sustituidas como moduladores de receptores tipo toll. |
| US9302013B2 (en) | 2011-01-31 | 2016-04-05 | Termira Ab | Active principle for mitigating undesired medical conditions |
| KR20150118106A (ko) | 2012-12-20 | 2015-10-21 | 알데이라 테라퓨틱스, 아이엔씨. | 페리-카르비놀 |
| CN111135171B (zh) | 2013-01-23 | 2023-09-08 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
-
2014
- 2014-01-21 AU AU2014209585A patent/AU2014209585A1/en not_active Abandoned
- 2014-01-21 CA CA2898869A patent/CA2898869A1/en not_active Abandoned
- 2014-01-21 JP JP2015555214A patent/JP6266023B2/ja not_active Expired - Fee Related
- 2014-01-21 CN CN201480005973.2A patent/CN105228989A/zh active Pending
- 2014-01-21 KR KR1020157022937A patent/KR20150120380A/ko not_active Withdrawn
- 2014-01-21 HK HK16105524.6A patent/HK1217490A1/zh unknown
- 2014-01-21 RU RU2015126015A patent/RU2015126015A/ru not_active Application Discontinuation
- 2014-01-21 US US14/760,041 patent/US10111862B2/en active Active
- 2014-01-21 MX MX2015009444A patent/MX2015009444A/es unknown
- 2014-01-21 SG SG11201505599YA patent/SG11201505599YA/en unknown
- 2014-01-21 EP EP14743787.5A patent/EP2948436A4/en not_active Withdrawn
- 2014-01-21 WO PCT/US2014/012356 patent/WO2014116593A1/en not_active Ceased
-
2015
- 2015-07-01 IL IL239736A patent/IL239736A0/en unknown
-
2018
- 2018-10-23 US US16/168,309 patent/US20190125729A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2898869A1 (en) | 2014-07-31 |
| US10111862B2 (en) | 2018-10-30 |
| RU2015126015A (ru) | 2017-03-03 |
| AU2014209585A1 (en) | 2015-07-23 |
| EP2948436A4 (en) | 2016-07-13 |
| MX2015009444A (es) | 2016-04-15 |
| US20190125729A1 (en) | 2019-05-02 |
| WO2014116593A1 (en) | 2014-07-31 |
| EP2948436A1 (en) | 2015-12-02 |
| KR20150120380A (ko) | 2015-10-27 |
| JP6266023B2 (ja) | 2018-01-24 |
| US20150344447A1 (en) | 2015-12-03 |
| CN105228989A (zh) | 2016-01-06 |
| SG11201505599YA (en) | 2015-08-28 |
| JP2016505637A (ja) | 2016-02-25 |
| IL239736A0 (en) | 2015-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256085B (en) | A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment | |
| HK1220980A1 (zh) | 用於治疗庞贝氏症的方法和组合物 | |
| EP3224278A4 (en) | Methods and formulations for treating vascular eye diseases | |
| EP3157463A4 (en) | Methods and devices for treating posterior ocular disorders | |
| EP3096617A4 (en) | Compositions and methods for treating ocular diseases | |
| IL239736A0 (en) | New pitfalls in the treatment of macular degeneration | |
| LT3206497T (lt) | Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui | |
| WO2013022740A3 (en) | Gpr35 ligands and the uses thereof | |
| IL271728A (en) | Materials, uses and treatment methods | |
| SG11201606101WA (en) | Compositions and methods for treating and preventing macular degeneration | |
| SG10201708547YA (en) | Compositions and methods for treating and preventing macular degeneration | |
| EP3095423A4 (en) | Disposable pant-type underwear, and manufacturing method therefor | |
| WO2016007540A3 (en) | Compositions and methods for treating dengue virus infection | |
| LT3229790T (lt) | Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme | |
| EP3240778A4 (en) | Methods and agents for treating disease | |
| EP3192512A4 (en) | Novel pharmaceutical composition for urinary incontinence prevention and/or treatment | |
| LT3157918T (lt) | 2-aril-4-hidroksi-1,3-tiazolo dariniai, tinkami naudoti kaip trpm8-inhibitoriai neuralgijos, skausmo, lėtinės obstrukcinės plaučių ligos (lopl) ar astmos gydymui | |
| EP3103446A4 (en) | Pharmaceutical preparation for preventing and treating progressive myopia | |
| GB2554624B (en) | Process for the Treatment of Ashes and Digestates, Treated Ashes and Digestates thus obtained and uses thereof. | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| IL252394A0 (en) | Methods for preventing, reducing or treating macular degeneration | |
| ZA201608558B (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
| EP3235808A4 (en) | Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same | |
| EP3139744A4 (en) | Methods and compositions for treating and preventing tinnitus | |
| EP3183270A4 (en) | Hiv antibody therapy as treatment substitute |